An evaluation of the protective effect of esomeprazole in an experimental model of renal ischemia–reperfusion

Purpose The ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the damaged kidney. The aim of this study is to evaluate, both biochemically and histologically, the efficacy of esomeprazole in an ischemia–rep...

Full description

Saved in:
Bibliographic Details
Published inInternational urology and nephrology Vol. 50; no. 2; pp. 217 - 223
Main Authors Ozkan, Tayyar Alp, Karakoyunlu, Nihat, Polat, Reyhan, Sarıbaş, Gülistan Sanem, Şener, Nevzat Can, Özdemir, Seyda, Peker, Kevser, Ünal, Dilek, Tuygun, Can
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.02.2018
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose The ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the damaged kidney. The aim of this study is to evaluate, both biochemically and histologically, the efficacy of esomeprazole in an ischemia–reperfusion model in rat kidneys. Methods The rats were randomized into three groups of seven animals each, referred to as the sham, control, and PPI groups. In the sham group, only a laparotomy was performed. In the control group, following laparotomy the left renal artery was dissected and tied for 30-min ischemia. In the PPI group, a vascular route to the tail vein was opened, and 10 mg/kg esomeprazole was administered. After 1 h, the same procedures described for the control group were performed. All the animals were killed 24 h after the procedure. Biochemical analyses were applied for evaluation of oxidant and antioxidant agents in the blood and left kidney of each subject (oxidative markers: malondialdehyde, myeloperoxidase; antioxidant marker: superoxide dismutase). In the histological examination of the kidney tissues stained with hematoxylin–eosin, the TUNEL method was applied in the evaluation of apoptosis. Results No statistically significant biochemical difference was determined in the blood and tissue samples. In the histological and apoptosis evaluations, a statistically significant difference was determined between the sham, control, and PPI groups. The median (IQR) values of the TUNEL-positive cells were counted as 1.50 (4) in the sham group, 11.50 (12) in the control group, and 6.00 (9) in the PPI group ( p  < 0.001). Conclusions A protective effect of esomeprazole was confirmed in renal ischemia–reperfusion damage created in an experimental rat model.
AbstractList PURPOSEThe ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the damaged kidney. The aim of this study is to evaluate, both biochemically and histologically, the efficacy of esomeprazole in an ischemia-reperfusion model in rat kidneys.METHODSThe rats were randomized into three groups of seven animals each, referred to as the sham, control, and PPI groups. In the sham group, only a laparotomy was performed. In the control group, following laparotomy the left renal artery was dissected and tied for 30-min ischemia. In the PPI group, a vascular route to the tail vein was opened, and 10 mg/kg esomeprazole was administered. After 1 h, the same procedures described for the control group were performed. All the animals were killed 24 h after the procedure. Biochemical analyses were applied for evaluation of oxidant and antioxidant agents in the blood and left kidney of each subject (oxidative markers: malondialdehyde, myeloperoxidase; antioxidant marker: superoxide dismutase). In the histological examination of the kidney tissues stained with hematoxylin-eosin, the TUNEL method was applied in the evaluation of apoptosis.RESULTSNo statistically significant biochemical difference was determined in the blood and tissue samples. In the histological and apoptosis evaluations, a statistically significant difference was determined between the sham, control, and PPI groups. The median (IQR) values of the TUNEL-positive cells were counted as 1.50 (4) in the sham group, 11.50 (12) in the control group, and 6.00 (9) in the PPI group (p < 0.001).CONCLUSIONSA protective effect of esomeprazole was confirmed in renal ischemia-reperfusion damage created in an experimental rat model.
Purpose The ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the damaged kidney. The aim of this study is to evaluate, both biochemically and histologically, the efficacy of esomeprazole in an ischemia–reperfusion model in rat kidneys. Methods The rats were randomized into three groups of seven animals each, referred to as the sham, control, and PPI groups. In the sham group, only a laparotomy was performed. In the control group, following laparotomy the left renal artery was dissected and tied for 30-min ischemia. In the PPI group, a vascular route to the tail vein was opened, and 10 mg/kg esomeprazole was administered. After 1 h, the same procedures described for the control group were performed. All the animals were killed 24 h after the procedure. Biochemical analyses were applied for evaluation of oxidant and antioxidant agents in the blood and left kidney of each subject (oxidative markers: malondialdehyde, myeloperoxidase; antioxidant marker: superoxide dismutase). In the histological examination of the kidney tissues stained with hematoxylin–eosin, the TUNEL method was applied in the evaluation of apoptosis. Results No statistically significant biochemical difference was determined in the blood and tissue samples. In the histological and apoptosis evaluations, a statistically significant difference was determined between the sham, control, and PPI groups. The median (IQR) values of the TUNEL-positive cells were counted as 1.50 (4) in the sham group, 11.50 (12) in the control group, and 6.00 (9) in the PPI group ( p  < 0.001). Conclusions A protective effect of esomeprazole was confirmed in renal ischemia–reperfusion damage created in an experimental rat model.
PurposeThe ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the damaged kidney. The aim of this study is to evaluate, both biochemically and histologically, the efficacy of esomeprazole in an ischemia–reperfusion model in rat kidneys.MethodsThe rats were randomized into three groups of seven animals each, referred to as the sham, control, and PPI groups. In the sham group, only a laparotomy was performed. In the control group, following laparotomy the left renal artery was dissected and tied for 30-min ischemia. In the PPI group, a vascular route to the tail vein was opened, and 10 mg/kg esomeprazole was administered. After 1 h, the same procedures described for the control group were performed. All the animals were killed 24 h after the procedure. Biochemical analyses were applied for evaluation of oxidant and antioxidant agents in the blood and left kidney of each subject (oxidative markers: malondialdehyde, myeloperoxidase; antioxidant marker: superoxide dismutase). In the histological examination of the kidney tissues stained with hematoxylin–eosin, the TUNEL method was applied in the evaluation of apoptosis.ResultsNo statistically significant biochemical difference was determined in the blood and tissue samples. In the histological and apoptosis evaluations, a statistically significant difference was determined between the sham, control, and PPI groups. The median (IQR) values of the TUNEL-positive cells were counted as 1.50 (4) in the sham group, 11.50 (12) in the control group, and 6.00 (9) in the PPI group (p < 0.001).ConclusionsA protective effect of esomeprazole was confirmed in renal ischemia–reperfusion damage created in an experimental rat model.
The ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the damaged kidney. The aim of this study is to evaluate, both biochemically and histologically, the efficacy of esomeprazole in an ischemia-reperfusion model in rat kidneys. The rats were randomized into three groups of seven animals each, referred to as the sham, control, and PPI groups. In the sham group, only a laparotomy was performed. In the control group, following laparotomy the left renal artery was dissected and tied for 30-min ischemia. In the PPI group, a vascular route to the tail vein was opened, and 10 mg/kg esomeprazole was administered. After 1 h, the same procedures described for the control group were performed. All the animals were killed 24 h after the procedure. Biochemical analyses were applied for evaluation of oxidant and antioxidant agents in the blood and left kidney of each subject (oxidative markers: malondialdehyde, myeloperoxidase; antioxidant marker: superoxide dismutase). In the histological examination of the kidney tissues stained with hematoxylin-eosin, the TUNEL method was applied in the evaluation of apoptosis. No statistically significant biochemical difference was determined in the blood and tissue samples. In the histological and apoptosis evaluations, a statistically significant difference was determined between the sham, control, and PPI groups. The median (IQR) values of the TUNEL-positive cells were counted as 1.50 (4) in the sham group, 11.50 (12) in the control group, and 6.00 (9) in the PPI group (p < 0.001). A protective effect of esomeprazole was confirmed in renal ischemia-reperfusion damage created in an experimental rat model.
Author Tuygun, Can
Şener, Nevzat Can
Sarıbaş, Gülistan Sanem
Peker, Kevser
Ozkan, Tayyar Alp
Karakoyunlu, Nihat
Polat, Reyhan
Özdemir, Seyda
Ünal, Dilek
Author_xml – sequence: 1
  givenname: Tayyar Alp
  orcidid: 0000-0003-3115-3141
  surname: Ozkan
  fullname: Ozkan, Tayyar Alp
  email: tayyaralp.ozkan@saglik.gov.tr
  organization: Department of Urology, Kocaeli Derince Training and Research Hospital, Saglik Bilimleri University
– sequence: 2
  givenname: Nihat
  surname: Karakoyunlu
  fullname: Karakoyunlu, Nihat
  organization: Department of Urology, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Saglik Bilimleri University
– sequence: 3
  givenname: Reyhan
  surname: Polat
  fullname: Polat, Reyhan
  organization: Department of Anesthesiology, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Saglik Bilimleri University
– sequence: 4
  givenname: Gülistan Sanem
  surname: Sarıbaş
  fullname: Sarıbaş, Gülistan Sanem
  organization: Department of Histology and Embryology, Gazi University
– sequence: 5
  givenname: Nevzat Can
  surname: Şener
  fullname: Şener, Nevzat Can
  organization: Department of Urology, Adana Numune Training and Research Hospital, Saglik Bilimleri University
– sequence: 6
  givenname: Seyda
  surname: Özdemir
  fullname: Özdemir, Seyda
  organization: Department of Biochemistry, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Saglik Bilimleri University
– sequence: 7
  givenname: Kevser
  surname: Peker
  fullname: Peker, Kevser
  organization: Department of Anesthesiology, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Saglik Bilimleri University
– sequence: 8
  givenname: Dilek
  surname: Ünal
  fullname: Ünal, Dilek
  organization: Department of Anesthesiology, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Saglik Bilimleri University
– sequence: 9
  givenname: Can
  surname: Tuygun
  fullname: Tuygun, Can
  organization: Department of Urology, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Saglik Bilimleri University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29280047$$D View this record in MEDLINE/PubMed
BookMark eNp1kcFO3DAQhq2KqizQB-ilisSll5QZJ46dI0ItICH1AmfLm4xLUGIvdoJoT32HvmGfhNkurSqknjzW__0zHv8HYi_EQEK8Q_iIAPokI0qlSkBdotaqNK_ECpWuSqlMvSdWUAGW2MhqXxzkfAcArQF4I_ZlK7mo9UrE01DQgxsXNw8xFNEX8y0VmxRn6ubhgQrynqutQDlOtEnuexypGELh2Pm4oTRMFGY3FlPsadyCiQJfh9zd0jS4Xz9-JmLML5knHInX3o2Z3j6fh-Lm86frs4vy6sv55dnpVdnVTT2XppHtmpx0VCtYm9qDApJGdmujgZwmRbLpqr4C07LYOICmN6Bcj-Sx99Wh-LDry6vcL5RnO_GDaBxdoLhki61BUDXbGD1-gd7FJfEKvymoEXVTMYU7qksx50Tebnhzl75ZBLtNw-7SsJyG3aZhDXveP3de1hP1fx1_vp8BuQMyS-ErpX9G_7frE7iwmH8
CitedBy_id crossref_primary_10_1016_j_amjsurg_2020_02_025
crossref_primary_10_5114_aoms_2019_89893
crossref_primary_10_1590_s1677_5538_ibju_2020_0358
crossref_primary_10_1681_ASN_2019060570
Cites_doi 10.1016/j.jss.2014.08.015
10.1016/0076-6879(90)86134-H
10.1016/j.arcmed.2005.05.018
10.1016/S0039-6109(16)45628-8
10.1016/j.jvs.2005.08.032
10.1016/j.ijcard.2004.10.018
10.1093/carcin/14.6.1195
10.1053/j.ackd.2009.02.002
10.1007/s11894-008-0098-4
10.1016/j.gene.2014.03.021
10.4103/0253-7613.153427
10.1152/ajpcell.00084.2014
10.1016/j.cccn.2004.03.035
10.1089/end.2013.0446
10.1186/1749-8090-9-35
10.4103/1319-2442.128512
10.1152/ajprenal.2001.281.2.F357
10.1152/ajprenal.90723.2008
10.1172/JCI114165
10.5152/tud.2014.53765
10.1016/S0021-9258(19)52451-6
10.5935/1678-9741.20150020
ContentType Journal Article
Copyright Springer Science+Business Media B.V., part of Springer Nature 2017
International Urology and Nephrology is a copyright of Springer, (2017). All Rights Reserved.
Copyright_xml – notice: Springer Science+Business Media B.V., part of Springer Nature 2017
– notice: International Urology and Nephrology is a copyright of Springer, (2017). All Rights Reserved.
DBID NPM
AAYXX
CITATION
3V.
7QP
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s11255-017-1775-8
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

ProQuest One Academic Eastern Edition
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: ProQuest Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-2584
EndPage 223
ExternalDocumentID 10_1007_s11255_017_1775_8
29280047
Genre Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
2.D
203
28-
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACUDM
ACVWB
ACWMK
ADBBV
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFEXP
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LLZTM
M1P
M4Y
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z7W
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
~A9
~EX
AACDK
AAJBT
AASML
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
ALIPV
H13
NPM
AAEOY
AAYXX
AJOOF
CITATION
7QP
7XB
8FK
K9.
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c464t-8629bea2ae450b84f050e282cb870ea7e5e26c3d30894f06a006d805ad1ef1df3
IEDL.DBID 7X7
ISSN 0301-1623
IngestDate Fri Aug 16 11:36:24 EDT 2024
Fri Sep 13 06:27:49 EDT 2024
Thu Sep 12 17:57:56 EDT 2024
Sat Sep 28 08:50:35 EDT 2024
Sat Dec 16 12:01:37 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Proton pump inhibitors
Ischemia–reperfusion injury
Rat
Esomeprazole
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c464t-8629bea2ae450b84f050e282cb870ea7e5e26c3d30894f06a006d805ad1ef1df3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3115-3141
PMID 29280047
PQID 1980411763
PQPubID 33540
PageCount 7
ParticipantIDs proquest_miscellaneous_1981054006
proquest_journals_1980411763
crossref_primary_10_1007_s11255_017_1775_8
pubmed_primary_29280047
springer_journals_10_1007_s11255_017_1775_8
PublicationCentury 2000
PublicationDate 2018-02-01
PublicationDateYYYYMMDD 2018-02-01
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-02-01
  day: 01
PublicationDecade 2010
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Netherlands
PublicationTitle International urology and nephrology
PublicationTitleAbbrev Int Urol Nephrol
PublicationTitleAlternate Int Urol Nephrol
PublicationYear 2018
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References Shin, Sachs (CR5) 2008; 10
Liuzzo, Ambrose, Das, Devoe, Korabathina, Agarwal, Deshmukh, Coppola (CR23) 2011; 23
Khader, Yang, Kuncewitch, Prince, Marambaud, Nicastro, Coppa, Wang (CR19) 2015; 193
Wei, Frenkel (CR13) 1993; 14
Yagmurca, Erdogan, Iraz, Songur, Ucar, Fadillioglu (CR11) 2004; 348
Jeremic, Petkovic, Srejovic, Zivkovic, Djuric, Jakovljevic (CR10) 2015; 30
Pektas, Gemalmaz, Balkaya, Unsal, Yenisey, Kilicarslan, Culhaci (CR16) 2014; 40
Funahashi, Kato, Yoshino, Fujita, Sassa, Gotoh (CR4) 2014; 28
Sagiroglu, Sezer, Torun, Yalta, Yagci, Sagiroglu, Copuroglu (CR22) 2014; 25
Chander, Chopra (CR17) 2005; 42
Pauly (CR3) 2009; 16
Yener, Cicek, Genc, Ozkan, Dogan, Bilgin, Akin, Erdem, Ankarali (CR21) 2014; 9
Dobrzycki, Baniukiewicz, Korecki, Bachorzewska-Gajewska, Prokopczuk, Musial, Kaminski, Dabrowski (CR9) 2005; 104
Birbrair, Zhang, Wang, Messi, Olson, Mintz, Delbono (CR1) 2014; 307
Wingo (CR7) 1989; 84
Verlander, Moudy, Campbell, Cain, Wingo (CR8) 2001; 281
Merter, Mayir, Erdogan, Colak (CR15) 2015; 47
Zimmerman, Granger (CR2) 1992; 72
Esterbauer, Cheeseman (CR14) 1990; 186
Li, Zhang, Zhang, Li, Yu, Zhang, Tan, Jiang, Wang, Liang, Zhang, Wang, Liu (CR20) 2014; 542
Chander, Chopra (CR18) 2006; 37
Gumz, Lynch, Greenlee, Cain, Wingo (CR6) 2010; 298
Lowry, Rosebrough, Farr, Randall (CR12) 1951; 193
H Esterbauer (1775_CR14) 1990; 186
YW Li (1775_CR20) 2014; 542
H Wei (1775_CR13) 1993; 14
CS Wingo (1775_CR7) 1989; 84
JW Verlander (1775_CR8) 2001; 281
OH Lowry (1775_CR12) 1951; 193
JM Shin (1775_CR5) 2008; 10
AA Merter (1775_CR15) 2015; 47
S Dobrzycki (1775_CR9) 2005; 104
M Yagmurca (1775_CR11) 2004; 348
V Chander (1775_CR17) 2005; 42
A Birbrair (1775_CR1) 2014; 307
Y Funahashi (1775_CR4) 2014; 28
J Liuzzo (1775_CR23) 2011; 23
RP Pauly (1775_CR3) 2009; 16
AU Yener (1775_CR21) 2014; 9
V Chander (1775_CR18) 2006; 37
A Pektas (1775_CR16) 2014; 40
ML Gumz (1775_CR6) 2010; 298
N Jeremic (1775_CR10) 2015; 30
BJ Zimmerman (1775_CR2) 1992; 72
A Khader (1775_CR19) 2015; 193
T Sagiroglu (1775_CR22) 2014; 25
References_xml – volume: 193
  start-page: 807
  issue: 2
  year: 2015
  end-page: 815
  ident: CR19
  article-title: Novel resveratrol analogues attenuate renal ischemic injury in rats
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2014.08.015
  contributor:
    fullname: Wang
– volume: 186
  start-page: 407
  year: 1990
  end-page: 421
  ident: CR14
  article-title: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal
  publication-title: Methods Enzymol
  doi: 10.1016/0076-6879(90)86134-H
  contributor:
    fullname: Cheeseman
– volume: 37
  start-page: 19
  issue: 1
  year: 2006
  end-page: 26
  ident: CR18
  article-title: Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats
  publication-title: Arch Med Res
  doi: 10.1016/j.arcmed.2005.05.018
  contributor:
    fullname: Chopra
– volume: 72
  start-page: 65
  issue: 1
  year: 1992
  end-page: 83
  ident: CR2
  article-title: Reperfusion injury
  publication-title: Surg Clin North Am
  doi: 10.1016/S0039-6109(16)45628-8
  contributor:
    fullname: Granger
– volume: 42
  start-page: 1198
  issue: 6
  year: 2005
  end-page: 1205
  ident: CR17
  article-title: Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning
  publication-title: J Vasc Surg
  doi: 10.1016/j.jvs.2005.08.032
  contributor:
    fullname: Chopra
– volume: 104
  start-page: 67
  issue: 1
  year: 2005
  end-page: 72
  ident: CR9
  article-title: Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD?
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2004.10.018
  contributor:
    fullname: Dabrowski
– volume: 14
  start-page: 1195
  issue: 6
  year: 1993
  end-page: 1201
  ident: CR13
  article-title: Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/14.6.1195
  contributor:
    fullname: Frenkel
– volume: 16
  start-page: 169
  issue: 3
  year: 2009
  end-page: 172
  ident: CR3
  article-title: Nocturnal home hemodialysis and short daily hemodialysis compared with kidney transplantation: emerging data in a new era
  publication-title: Adv Chronic Kidney Dis
  doi: 10.1053/j.ackd.2009.02.002
  contributor:
    fullname: Pauly
– volume: 10
  start-page: 528
  issue: 6
  year: 2008
  end-page: 534
  ident: CR5
  article-title: Pharmacology of proton pump inhibitors
  publication-title: Curr Gastroenterol Rep
  doi: 10.1007/s11894-008-0098-4
  contributor:
    fullname: Sachs
– volume: 542
  start-page: 46
  issue: 1
  year: 2014
  end-page: 51
  ident: CR20
  article-title: Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-kappaB p65 signal pathway
  publication-title: Gene
  doi: 10.1016/j.gene.2014.03.021
  contributor:
    fullname: Liu
– volume: 47
  start-page: 185
  issue: 2
  year: 2015
  end-page: 189
  ident: CR15
  article-title: Protective effects of amifostine on ischemia-reperfusion injury of rat kidneys
  publication-title: Indian J Pharmacol
  doi: 10.4103/0253-7613.153427
  contributor:
    fullname: Colak
– volume: 193
  start-page: 265
  issue: 1
  year: 1951
  end-page: 275
  ident: CR12
  article-title: Protein measurement with the Folin phenol reagent
  publication-title: J Biol Chem
  contributor:
    fullname: Randall
– volume: 307
  start-page: C25
  issue: 1
  year: 2014
  end-page: C38
  ident: CR1
  article-title: Type-2 pericytes participate in normal and tumoral angiogenesis
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00084.2014
  contributor:
    fullname: Delbono
– volume: 348
  start-page: 27
  issue: 1–2
  year: 2004
  end-page: 34
  ident: CR11
  article-title: Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cccn.2004.03.035
  contributor:
    fullname: Fadillioglu
– volume: 30
  start-page: 266
  issue: 2
  year: 2015
  end-page: 275
  ident: CR10
  article-title: Effects of ischemia and omeprazole preconditioning on functional recovery of isolated rat heart
  publication-title: Rev Bras Cir Cardiovasc
  contributor:
    fullname: Jakovljevic
– volume: 28
  start-page: 306
  issue: 3
  year: 2014
  end-page: 311
  ident: CR4
  article-title: Comparison of renal ischemic damage during laparoscopic partial nephrectomy with artery-vein and artery-only clamping
  publication-title: J Endourol
  doi: 10.1089/end.2013.0446
  contributor:
    fullname: Gotoh
– volume: 9
  start-page: 35
  year: 2014
  ident: CR21
  article-title: Protective role of heparin in the injury of the liver and kidney on the experimental model of ischemia/reperfusion
  publication-title: J Cardiothorac Surg
  doi: 10.1186/1749-8090-9-35
  contributor:
    fullname: Ankarali
– volume: 25
  start-page: 294
  issue: 2
  year: 2014
  end-page: 302
  ident: CR22
  article-title: Protective effect of everolimus on renal ischemia reperfusion injury in rats
  publication-title: Saudi J Kidney Dis Transpl
  doi: 10.4103/1319-2442.128512
  contributor:
    fullname: Copuroglu
– volume: 23
  start-page: 222
  issue: 6
  year: 2011
  end-page: 226
  ident: CR23
  article-title: Prospective, randomized, placebo-controlled evaluation of esomeprazole in coronary artery disease patients. EPAC: esomeprazole prevention of atypical chest pains
  publication-title: J Invasive Cardiol
  contributor:
    fullname: Coppola
– volume: 281
  start-page: F357
  issue: 2
  year: 2001
  end-page: F365
  ident: CR8
  article-title: Immunohistochemical localization of H-K-ATPase alpha(2c)-subunit in rabbit kidney
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.2001.281.2.F357
  contributor:
    fullname: Wingo
– volume: 298
  start-page: F12
  issue: 1
  year: 2010
  end-page: F21
  ident: CR6
  article-title: The renal H -K -ATPases: physiology, regulation, and structure
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.90723.2008
  contributor:
    fullname: Wingo
– volume: 84
  start-page: 361
  issue: 1
  year: 1989
  end-page: 365
  ident: CR7
  article-title: Active proton secretion and potassium absorption in the rabbit outer medullary collecting duct. Functional evidence for proton-potassium-activated adenosine triphosphatase
  publication-title: J Clin Invest
  doi: 10.1172/JCI114165
  contributor:
    fullname: Wingo
– volume: 40
  start-page: 46
  issue: 1
  year: 2014
  end-page: 51
  ident: CR16
  article-title: The short-term protective effects of lycopene on renal ischemia-reperfusion injury in rats
  publication-title: Turk J Urol
  doi: 10.5152/tud.2014.53765
  contributor:
    fullname: Culhaci
– volume: 193
  start-page: 265
  issue: 1
  year: 1951
  ident: 1775_CR12
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)52451-6
  contributor:
    fullname: OH Lowry
– volume: 281
  start-page: F357
  issue: 2
  year: 2001
  ident: 1775_CR8
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.2001.281.2.F357
  contributor:
    fullname: JW Verlander
– volume: 42
  start-page: 1198
  issue: 6
  year: 2005
  ident: 1775_CR17
  publication-title: J Vasc Surg
  doi: 10.1016/j.jvs.2005.08.032
  contributor:
    fullname: V Chander
– volume: 9
  start-page: 35
  year: 2014
  ident: 1775_CR21
  publication-title: J Cardiothorac Surg
  doi: 10.1186/1749-8090-9-35
  contributor:
    fullname: AU Yener
– volume: 10
  start-page: 528
  issue: 6
  year: 2008
  ident: 1775_CR5
  publication-title: Curr Gastroenterol Rep
  doi: 10.1007/s11894-008-0098-4
  contributor:
    fullname: JM Shin
– volume: 14
  start-page: 1195
  issue: 6
  year: 1993
  ident: 1775_CR13
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/14.6.1195
  contributor:
    fullname: H Wei
– volume: 348
  start-page: 27
  issue: 1–2
  year: 2004
  ident: 1775_CR11
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cccn.2004.03.035
  contributor:
    fullname: M Yagmurca
– volume: 84
  start-page: 361
  issue: 1
  year: 1989
  ident: 1775_CR7
  publication-title: J Clin Invest
  doi: 10.1172/JCI114165
  contributor:
    fullname: CS Wingo
– volume: 186
  start-page: 407
  year: 1990
  ident: 1775_CR14
  publication-title: Methods Enzymol
  doi: 10.1016/0076-6879(90)86134-H
  contributor:
    fullname: H Esterbauer
– volume: 47
  start-page: 185
  issue: 2
  year: 2015
  ident: 1775_CR15
  publication-title: Indian J Pharmacol
  doi: 10.4103/0253-7613.153427
  contributor:
    fullname: AA Merter
– volume: 37
  start-page: 19
  issue: 1
  year: 2006
  ident: 1775_CR18
  publication-title: Arch Med Res
  doi: 10.1016/j.arcmed.2005.05.018
  contributor:
    fullname: V Chander
– volume: 23
  start-page: 222
  issue: 6
  year: 2011
  ident: 1775_CR23
  publication-title: J Invasive Cardiol
  contributor:
    fullname: J Liuzzo
– volume: 104
  start-page: 67
  issue: 1
  year: 2005
  ident: 1775_CR9
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2004.10.018
  contributor:
    fullname: S Dobrzycki
– volume: 307
  start-page: C25
  issue: 1
  year: 2014
  ident: 1775_CR1
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00084.2014
  contributor:
    fullname: A Birbrair
– volume: 40
  start-page: 46
  issue: 1
  year: 2014
  ident: 1775_CR16
  publication-title: Turk J Urol
  doi: 10.5152/tud.2014.53765
  contributor:
    fullname: A Pektas
– volume: 72
  start-page: 65
  issue: 1
  year: 1992
  ident: 1775_CR2
  publication-title: Surg Clin North Am
  doi: 10.1016/S0039-6109(16)45628-8
  contributor:
    fullname: BJ Zimmerman
– volume: 298
  start-page: F12
  issue: 1
  year: 2010
  ident: 1775_CR6
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.90723.2008
  contributor:
    fullname: ML Gumz
– volume: 542
  start-page: 46
  issue: 1
  year: 2014
  ident: 1775_CR20
  publication-title: Gene
  doi: 10.1016/j.gene.2014.03.021
  contributor:
    fullname: YW Li
– volume: 16
  start-page: 169
  issue: 3
  year: 2009
  ident: 1775_CR3
  publication-title: Adv Chronic Kidney Dis
  doi: 10.1053/j.ackd.2009.02.002
  contributor:
    fullname: RP Pauly
– volume: 30
  start-page: 266
  issue: 2
  year: 2015
  ident: 1775_CR10
  publication-title: Rev Bras Cir Cardiovasc
  doi: 10.5935/1678-9741.20150020
  contributor:
    fullname: N Jeremic
– volume: 25
  start-page: 294
  issue: 2
  year: 2014
  ident: 1775_CR22
  publication-title: Saudi J Kidney Dis Transpl
  doi: 10.4103/1319-2442.128512
  contributor:
    fullname: T Sagiroglu
– volume: 28
  start-page: 306
  issue: 3
  year: 2014
  ident: 1775_CR4
  publication-title: J Endourol
  doi: 10.1089/end.2013.0446
  contributor:
    fullname: Y Funahashi
– volume: 193
  start-page: 807
  issue: 2
  year: 2015
  ident: 1775_CR19
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2014.08.015
  contributor:
    fullname: A Khader
SSID ssj0009800
Score 2.2036602
Snippet Purpose The ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the...
The ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the damaged...
PurposeThe ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the...
PURPOSEThe ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 217
SubjectTerms Antioxidants
Apoptosis
Ischemia
Kidneys
Malondialdehyde
Medicine
Medicine & Public Health
Nephrectomy
Nephrology
Omeprazole
Parenchyma
Peroxidase
Renal artery
Reperfusion
Rodents
Statistical analysis
Superoxide dismutase
Tumors
Urology
Urology - Original Paper
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT-MwEB5BkRCX5c2W7SIjcQKlsp1HnWO1gq0WwQkkOEV2MpYqaIL6uHDiP_AP-SWM82hBXQ6cPYkTj8cz45n5BuBEy7J8UnpcZeSgGCW82KbKM1xopXup4mXE9Oo6GtwG_-7CuxWQ86uL_KHbRCTLg3pR60aq2OWZOUzDXuipVVgLXVfqFqz1_95fni-gdlVVeEJb1xOk3ZtY5v9e8lkbLZmYS-HRUutcbFaVgJMSrNAlmzx0Z1PTTZ-XoRy_8UNb8KM2Qlm_2jXbsIL5Dqxf1WH2XSj6OVvAgLPCMjITWQ3pQMcjq7JA3ABOihE-jfVz8YhsmDNNT35oGsDKTjuOcIxuyiE50zga6reX1zESmZ2527o9uL04v_kz8OrODF4aRMHUIzcoNqilxiDkRgWWhxzJeUsNiT_qHoYoo9TPfK5iGow0yXameKgzgVZk1t-HVl7k-BOYw8WVvlbCd5aGbw35Zz65-1ZJmxoTteG04VDyVAFwJAuoZbeECS1h4pYwUW3oNDxMalmcJCJ2GEuCDtI2HM-HSYpcaETnWMxKGuGMV07zHVS8n88mY6kcqGYbzhpGfnj5V59y-C3qX7BBlpiq0sE70JqOZ_ibrJ2pOaq39ztTz_Vi
  priority: 102
  providerName: Springer Nature
Title An evaluation of the protective effect of esomeprazole in an experimental model of renal ischemia–reperfusion
URI https://link.springer.com/article/10.1007/s11255-017-1775-8
https://www.ncbi.nlm.nih.gov/pubmed/29280047
https://www.proquest.com/docview/1980411763/abstract/
https://search.proquest.com/docview/1981054006
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LjxMxDLaWXQlxQbwpLKsgcQJFTTKv9IRa1FKBtkKISuU0SmYcqRI7U7rthRP_gX_IL8Gex3bRCk45ODOJnDi2Y_sLwCtnmvJJI5UtyUHxVstRKKz0SjvrssKqJmJ6vkjny_jDKlkdwbyvheG0yv5MbA7qsi74jnxIzrGKtSZxGDrPtwDFbvh2813y-1EcZ-0e07gFJ9qQWUE7O1tlB_hd2xaj0HaWmjR-H99siuhIx3MCG4MlZom0f2uoG2bnjZBpo4lm9-BuZ0KKcbvm9-EIqwdw-7wLkj-EelyJA4i3qIMgI090gAx0uIk2h4MJeFlf4GbrftTfUKwr4ejLa5D_onknhztukYdckyuMF2v3--evLVK3sOe7tkewnE2_vJvL7l0FWcRpvJPkxIw8OuMwTpS3cVCJQnK9Ck_Ciy7DBE1aRGWk7IiIqSPJLK1KXKkx6DJEj-G4qit8CoJRbU3krI7YToiCJ-8qImc9WBMK79MBvO55mW9a-Iz8AJTMjM-J8TkzPrcDOO25nXeSdJkf1n0AL6_IJAMc2HAV1vumj2bTU9F4T9pVuhrNjIxlSMwBvOmX7drP_zWVZ_-fynO4Q4aTbbO3T-F4t93jCzJOdv6s2XdncDKeTSYLbt9__TildjJdfPpM1KUZ_wEiHuYw
link.rule.ids 315,786,790,12083,21416,27957,27958,31754,31755,33779,33780,41116,41558,42185,42627,43345,43840,52146,52269,74102,74659
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTxsxEB6VIBUuiLYUwqN1pZ5AVu19xTkhQKAUSFQhkLit7N2xFInshjwunPgP_EN-CeNdL6FC7dnetTXjsefzjL8B-KmD6vlkwIXKCaAYJXnXZoobIbXSnUyJKmLaHyS9m-j8Nr71F25Tn1bZ7InVRp2Xmbsj_0XgWERSkjkcju-5qxrloqu-hMYSLEchQZUWLB-fDv5cLWh3Vf0IhZYxl3TSN3HN6vEcne0ucc2RJHZirv4-md65m-9CpdUJdLYOa951ZEe1rj_BByw-w8e-D45_gfKoYAvyblZaRs4d80QMtKmxOnfDNeC0HOF4oh_KO2TDgmn68g3VP6vq47iOE3RDDgkC42ionx-fJkjd7NzdsW3Azdnp9UmP-3oKPIuSaMYJvHQN6kBjFAujIitigQS5MkNGi7qDMQZJFuahUF1qTDRZZK5ErHOJVuY2_AqtoixwC5hjsw1CrWTo_IPQGkJVIYF0qwKbGZO0Yb-RZTquaTPSBUGyE3xKgk-d4FPVht1G2qm3oGm60Hcbfrw209p3AQ1dYDmv-kjncgoab7PW0utoQTdQjgqzDQeN2t78_F9T2f7_VL7DSu-6f5le_h5c7MAqOU-qzuDehdZsMsc9clBm5ptfhS_-GuE2
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB4VKiEuqA8K29LWlTi1srDz9J4Qol3RB4hDkfYW2clYWolNln1ceup_6D_sL-lM4rAgRM92YmsenhnP-BuAQxu1zycjqUxFAYozWg59aaRT2hqbl0a1GdPzi-zsKvk2Tseh_mkRyir7M7E9qKum5DvyIwqOVaI1qcORD2URl59Hx7MbyR2kONMa2mlswFOykoq7GeTjfA3Aa7rnKCTQUpPN7zOc7TM6svJcwsZwiXkqzX0b9cDxfJA0bW3R6BnsBCdSnHRcfw5PsH4BW-chTf4SmpNarGG8ReMFuXkiQDLQ8Sa6Kg4ewEUzxdnc_mquUUxqYenLO6D_ou2UwxPnyEtOKBjG6cT-_f1njjTNr_i2bReuRl9-np7J0FlBlkmWLCWFMUOHNrKYpMqZxKtUIQVfpSP1RZtjilFWxlWszJAGM0u6WRmV2kqj15WPX8Fm3dS4D4JxbaPYGh2zpxB7R_FVTOG6N5EvncsG8LGnZTHrADSKNVQyE74gwhdM-MIM4KCndhF0aVGsOT-AD7fDpAWc2rA1Nqt2jmbnU9F6ex2XbleLhpFhUMwBfOrZdufnj23l9f-38h62SPyKH18vvr-BbfKiTFfKfQCby_kK35KnsnTvWhH8B6RF4_w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+evaluation+of+the+protective+effect+of+esomeprazole+in+an+experimental+model+of+renal+ischemia%E2%80%93reperfusion&rft.jtitle=International+urology+and+nephrology&rft.au=Ozkan%2C+Tayyar+Alp&rft.au=Karakoyunlu%2C+Nihat&rft.au=Polat%2C+Reyhan&rft.au=Sar%C4%B1ba%C5%9F%2C+G%C3%BClistan+Sanem&rft.date=2018-02-01&rft.issn=0301-1623&rft.eissn=1573-2584&rft.volume=50&rft.issue=2&rft.spage=217&rft.epage=223&rft_id=info:doi/10.1007%2Fs11255-017-1775-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11255_017_1775_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-1623&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-1623&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-1623&client=summon